Scientists try to 're-sensitize' resistant cancer cells to chemo
NCT ID NCT04664829
Summary
This small, early-stage study tested whether a drug called bexarotene could make chemotherapy-resistant triple-negative breast cancer cells vulnerable to treatment again. Researchers gave bexarotene to 12 patients with advanced, taxane-resistant cancer, hoping it would change the cancer cells' state and restore their sensitivity. The main goal was to see what biological changes happened in the tumors after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center Singapore
Singapore, 168583, Singapore
Conditions
Explore the condition pages connected to this study.